Vera Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| AVORO CAPITAL ADVISORS LLC | 11/14/2024 | 4.31 M | $190.48 M | 0.00% | 7.85% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 3.94 M | $174.11 M | 8.81% | 7.18% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 3.45 M | $152.59 M | 100.00% | 6.29% |
| SOFINNOVA INVESTMENTS, INC. | 11/13/2024 | 2.79 M | $123.49 B | 0.00% | 5.09% |
| FMR LLC | 11/13/2024 | 2.79 M | $123.11 M | -0.59% | 5.07% |
| VANGUARD GROUP INC | 11/13/2024 | 2.58 M | $114.04 M | 2.22% | 4.70% |
| COMMODORE CAPITAL LP | 11/14/2024 | 2.48 M | $109.40 M | 0.00% | 4.51% |
| EVERSEPT PARTNERS, LP | 11/14/2024 | 2.05 M | $90.62 M | 0.34% | 3.73% |
| HOLOCENE ADVISORS, LP | 11/14/2024 | 1.95 M | $86.39 M | 8.82% | 3.56% |
| STATE STREET CORP | 11/14/2024 | 1.82 M | $80.61 M | -15.39% | 3.32% |
| KYNAM CAPITAL MANAGEMENT, LP | 11/14/2024 | 1.58 M | $69.68 M | 2.13% | 2.87% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 1.37 M | $60.73 M | 22.79% | 2.50% |
| SAMLYN CAPITAL, LLC | 11/14/2024 | 1.36 M | $60.08 M | 10.33% | 2.48% |
| PARADIGM BIOCAPITAL ADVISORS LP | 11/14/2024 | 1.10 M | $48.48 M | 100.00% | 2.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.00 M | $44.41 M | 2.05% | 1.83% |
| WOODLINE PARTNERS LP | 11/14/2024 | 1.00 M | $44.24 M | 5.48% | 1.82% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 11/14/2024 | 984,001 | $43.49 M | 100.00% | 1.79% |
| SIREN, L.L.C. | 11/13/2024 | 837,928 | $37.04 B | 100.00% | 1.53% |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 11/14/2024 | 705,234 | $31.17 M | -29.88% | 1.28% |
| ALTIUM CAPITAL MANAGEMENT LP | 11/14/2024 | 684,000 | $30.23 M | -4.20% | 1.25% |
| ORBIMED ADVISORS LLC | 11/14/2024 | 675,872 | $29.87 M | 0.00% | 1.23% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 599,854 | $26.51 M | -23.54% | 1.09% |
| MARSHALL WACE, LLP | 11/14/2024 | 583,725 | $25.80 M | 11.28% | 1.06% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/12/2024 | 571,998 | $25.28 M | -8.28% | 1.04% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 11/14/2024 | 500,000 | $22.10 M | 0.00% | 0.91% |
| LOGOS GLOBAL MANAGEMENT LP | 11/14/2024 | 500,000 | $22.10 M | -47.37% | 0.91% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 11/13/2024 | 476,713 | $20.71 M | 10.05% | 0.87% |
| CANDRIAM S.C.A. | 11/13/2024 | 450,992 | $19.93 M | 53.52% | 0.82% |
| JENNISON ASSOCIATES LLC | 11/08/2024 | 447,098 | $19.76 M | 1.35% | 0.81% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2024 | 435,000 | $19.23 M | 16.00% | 0.79% |
| LORD, ABBETT & CO. LLC | 12/13/2024 | 426,014 | $18.83 M | 41.15% | 0.78% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 386,414 | $17.08 M | -0.25% | 0.70% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2024 | 383,492 | $16.95 M | 0.60% | 0.70% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 361,805 | $15.99 M | 3.05% | 0.66% |
| MORGAN STANLEY | 11/14/2024 | 341,076 | $15.08 M | 11.67% | 0.62% |
| FIRST TURN MANAGEMENT, LLC | 11/07/2024 | 326,494 | $14.43 M | 53.32% | 0.59% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 296,435 | $13.10 M | 787.61% | 0.54% |
| AXA S.A. | 11/14/2024 | 246,269 | $10.89 M | 0.03% | 0.45% |
| ALPHABET INC. | 11/08/2024 | 241,264 | $10.66 M | 0.00% | 0.44% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2024 | 196,350 | $8.68 M | -31.93% | 0.36% |
| TD ASSET MANAGEMENT INC | 11/01/2024 | 192,894 | $8.38 M | 24.98% | 0.35% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2024 | 175,591 | $7.76 M | 2,803.77% | 0.32% |
| CUTTER CAPITAL MANAGEMENT, LP | 11/14/2024 | 172,876 | $7.64 M | -24.84% | 0.31% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2024 | 171,573 | $7.58 M | 44.18% | 0.31% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 159,024 | $7.03 M | 12.11% | 0.29% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 11/12/2024 | 153,596 | $6.79 M | 266.43% | 0.28% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 11/08/2024 | 137,389 | $6.07 M | 0.71% | 0.25% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 136,917 | $6.05 M | -23.90% | 0.25% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 134,053 | $5.93 M | -18.91% | 0.24% |
| D. E. SHAW & CO., INC. | 11/14/2024 | 130,466 | $5.77 M | -64.80% | 0.24% |
Vera Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 201 institutional investors and hedge funds held shares of Vera Therapeutics, Inc.. The most heavily invested institutionals were:
Avoro Capital Advisors LLC: 4.31 M
PRICE T ROWE ASSOCIATES INC /MD/: 3.94 M
BlackRock Funding, Inc. /DE: 3.45 M
Sofinnova Investments, Inc.: 2.79 M
FMR LLC: 2.79 M
VANGUARD GROUP INC: 2.58 M
97.41% of Vera Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 61.26 M shares in the last 24 months. This purchase volume represents approximately $2.63 B in transactions.